Biocompatibility of Bletilla striata Microspheres as a Novel Embolic Agent

Table 2

Renal and liver function at different times.

Group	Time	ALT (U/L)	AST (U/L)	BUN (µmol/L)	Cr (mmol/L)
Experimental group	0 d	33.1 ± 12.1	29.8 ± 9.6	6.2 ± 2.1	59.2 ± 14.3
	1 d	28.3 ± 11.5	37.3 ± 13.2	5.9 ± 2.6	58.3 ± 24.1
	3 d	72.1 ± 25.6	63.7 ± 19.5	21.5 ± 7.6	140.6 ± 24.5
	7 d	38.4 ± 11.6	31.5 ± 7.9	19.2 ± 4.3	161.1 ± 36.2
	14 d	37.5 ± 5.9	30.3 ± 6.2	6.1 ± 1.9	96.4 ± 28.4
	21 d	31.5 ± 6.3	30.8 ± 7.3	7.3 ± 1.9	65.2 ± 13.5
	4 w	28.1 ± 7.5	32.6 ± 9.8	6.4 ± 2.1	63.9 ± 17.2
	6 w	26.6 ± 9.2	31.5 ± 10.5	6.7 ± 2.1	67.3 ± 15.7
	8 w	27.3 ± 9.3	30.5 ± 16.2	5.7 ± 1.8	64.8 ± 11.8
	12 w	36.7 ± 7.4	35.3 ± 9.3	6.5 ± 1.4	71.3 ± 17.6
Control group	0 d	35.7 ± 13.3	25.6 ± 9.2	5.3 ± 1.7	67.3 ± 16.4
	1 d	29.4 ± 14.6	35.2 ± 11.7	6.7 ± 2.4	73.1 ± 23.5
	3 d	71.1 ± 16.6	67.2 ± 21.6	19.3 ± 7.4	146.2 ± 32.7
	7 d	40.2 ± 12.1	29.4 ± 7.9	16.2 ± 3.5	135.9 ± 15.8
	14 d	36.1 ± 11.7	26.7 ± 9.3	6.4 ± 1.7	85.4 ± 21.5
	21 d	34.8 ± 13.3	32.6 ± 7.6	6.2 ± 1.9	63.1 ± 19.4
	4 w	32.9 ± 8.4	35.7 ± 9.8	5.5 ± 1.7	68.4 ± 13.1
	6 w	26.8 ± 3.7	26.2 ± 5.3	4.7 ± 1.6	61.2 ± 11.6
	8 w	29.4 ± 9.5	29.8 ± 5.1	5.1 ± 1.1	66.4 ± 12.4
	12 w	29.7 ± 8.2	31.3 ± 6.5	5.9 ± 1.7	70.3 ± 19.3